Providence Cancer Institute — Portland, Oregon

Providence Cancer Institute is a clinical research site located in Portland, Oregon, United States 97213.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Providence Cancer Institute has participated in 36 clinical trials with 20 currently active.

Therapeutic areas: Adult Solid Tumor, Epithelial Ovarian Cancer, Ovarian Cancer.

Sponsors: SQZ Biotechnologies, Imunon, Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Providence Cancer Institute?

Providence Cancer Institute has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Providence Cancer Institute conducted?

Providence Cancer Institute has 36 clinical trials on record, with 20 currently active. Their work covers Adult Solid Tumor, Epithelial Ovarian Cancer, Ovarian Cancer.

Is Providence Cancer Institute accredited by Crixeo Health?

Providence Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Providence Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.